Central Pharmacy Logistics Australia
Central Pharmacy Logistics Australia (CPL) is a privately-held Australian clinical trial supply chain specialist that delivers and collects Investigational Products directly to and from patients' homes via its TGA-licensed Melbourne depot, serving pharmaceutical sponsors, CROs, and researchers running decentralized clinical trials across Australia.
- Company typePrivate
- Founded2019
- HeadquartersMelbourne, Australia
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Central Pharmacy Logistics Australia does
Central Pharmacy Logistics Australia (CPL) is an Australian privately-held clinical trial supply chain specialist that delivers and collects Investigational Products (IP) directly to and from patients' homes through its Direct-to-Patient (DTP) and Direct-From-Patient (DFP) service models. The company is positioned as the 'Australian-first' decentralized clinical trial (DCT) distributor, targeting the country's rural and remote patient population — cited as close to 30% of Australians — that traditional site-based trials underserve. Customers are enterprise buyers: pharmaceutical companies, Contract Research Organisations (CROs), clinical trial sponsors, and academic researchers seeking improved recruitment and retention. Secondary channel partners include in-home care providers for administration and nursing coordination.
The underlying technology is operational rather than digital: a TGA-licensed, GMP-compliant depot in Coburg North, Melbourne (ten minutes from the international airport) with temperature monitoring, backup generator, 24/7 CCTV surveillance, and security checkpoints, staffed by GMP/GCP trained pharmacists accountable for dispensing. Distribution is executed by trained premium couriers to patient homes wherever located in Australia, with end-to-end project management from dispensing through to administration. The company describes itself as a supply-chain service rather than a software platform; no API, app, or AI/ML capability is disclosed.
CPL operates on a professional-services revenue model with quote-based pricing (not publicly disclosed) and a sales-led go-to-market using direct outreach, a website contact form, and organic LinkedIn and Twitter presence. The founder-CEO Rima Darwiche, a registered pharmacist with two decades of clinical research experience, leads the firm. The company is independently owned with no parent company, no disclosed funding rounds, and a single domestic operating geography, making it a small specialist contractor in a category with strong tailwinds from the global shift toward decentralized trials.
Central Pharmacy Logistics Australia firmographics
Firmographics- Name
- Central Pharmacy Logistics Australia
- Legal name
- Central Pharmacy Logistics Australia
- Website
- https://cplaustralia.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Central Pharmacy Logistics Australia (CPL) is a privately-held Australian clinical trial supply chain specialist that delivers and collects Investigational Products directly to and from patients' homes via its TGA-licensed Melbourne depot, serving pharmaceutical sponsors, CROs, and researchers running decentralized clinical trials across Australia.
- Ownership category
- akta.pro rank
Central Pharmacy Logistics Australia industry classification
Industry- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Clinical Trial Logistics & Depot Services (IRT-integrated, kitting, returns) (HLAGAMAC)
- akta.pro secondary industries
- Pharmaceutical & Life Sciences Warehousing (GDP-Compliant) (TLAIACAD), Clinical Specimen & Lab Diagnostics Courier (Blood, Tissue, Pathology) (TLAAAIAA)
Keywords
Where Central Pharmacy Logistics Australia is headquartered
LocationHeadquarters
- HQ city
- Melbourne
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Central Pharmacy Logistics Australia business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Clinical Trial Supply Chain Services: Professional services for clinical drug trial distribution including storage, dispensing, and Direct-to-Patient delivery of Investigational Products (IP). Revenue is generated through service fees for managing the complete supply chain from depot to patient homes.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Central Pharmacy Logistics Australia product offering
Product offeringCore offering
Central Pharmacy Logistics Australia provides Direct-to-Patient (DTP) delivery and Direct-From-Patient (DFP) collection of investigational products for clinical drug trials across Australia. Services are anchored at a TGA-licensed, GMP-compliant Melbourne depot operated by GMP/GCP-trained pharmacists, supported by premium couriers who deliver investigational products to and from patients' homes, enabling decentralised clinical trials.
Product overview
CPL offers a unified clinical trial supply chain platform centered on its Direct-to-Patient (DTP) and Direct-From-Patient (DFP) models. The DTP service enables investigational products to be delivered and administered at patients' homes, while the DFP service handles collection and return of products and samples. These services are supported by CPL's Melbourne-based depot, which provides temperature-controlled storage, GMP/GCP compliant dispensing by licensed pharmacists, and secure distribution through trained premium couriers.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Close to 30% of Australian population in rural/remote areas can participate in clinical trials
Companies that use Central Pharmacy Logistics Australia
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Central Pharmacy Logistics Australia technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Central Pharmacy Logistics Australia partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights4 records
Central Pharmacy Logistics Australia competitors and assessment
Company assessmentDirect peers
- Marken: Now part of UPS Healthcare, Marken is a global clinical trial logistics specialist offering Direct-to-Patient and Direct-From-Patient services, biologic specimen transport, and depot operations — a direct global counterpart to CPL's Australian DTP/DFP offering.
- Biocair: Biocair specializes in temperature-controlled life sciences logistics including clinical trial IMP distribution, biological sample transport, and decentralized trial support — a close functional analogue to CPL's GMP depot and DTP model.
- World Courier: Owned by Cencora, World Courier operates in over 50 countries with clinical trial supply chain, GMP-compliant storage, and DTP/DFP capabilities — overlapping directly with CPL's service portfolio at a materially larger scale.
- Movianto: Movianto (part of Walden) operates as a specialty pharmaceutical logistics provider offering warehousing, distribution, and clinical trial supply across Europe, with capabilities that closely mirror CPL's TGA-licensed depot and DTP focus.
- Yourway Transport: Yourway is a niche clinical trial logistics provider offering bio-pharmaceutical courier, clinical storage, and direct-to-patient services; functionally comparable to CPL though operating primarily in the Americas and Europe.
Emerging players
- Cryoport Systems: Cryoport provides temperature-controlled supply chain solutions for life sciences, including clinical trial logistics for cell and gene therapies. Its emerging focus on complex biologic trial logistics overlaps with parts of CPL's GMP/GCP-monitored DTP offering.
- Clinipace Worldwide (or dMed Global): Clinipace / dMed Global is a mid-sized CRO with embedded clinical supply and decentralized trial capabilities, offering overlapping support to sponsors running decentralized trials in Australia.
Broad incumbents
- Almac Group: Almac provides end-to-end clinical trial supply, including clinical trial packaging, distribution, and clinical technologies. Its global clinical supply chain services sit alongside CPL's specialist depot/DTP offering but at significantly broader scale.
- DHL Supply Chain (Life Sciences): DHL's Life Sciences division provides clinical trial logistics, cold-chain warehousing, and global distribution for pharmaceutical and biotech customers. As a broad incumbent, it competes with CPL on enterprise clinical trial contracts in Australia and the broader APAC region.
- Fisher Clinical Services (Thermo Fisher Scientific): Part of Thermo Fisher, Fisher Clinical Services offers clinical trial packaging, labeling, storage, and global distribution including direct-to-patient logistics — a broader-portfolio incumbent comparable to CPL's clinical supply chain services.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Central Pharmacy Logistics Australia social profiles
Digital presenceCentral Pharmacy Logistics Australia compliance and trust
Trust signalCompliance2 records
Central Pharmacy Logistics Australia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Central Pharmacy Logistics Australia leadership team
Management profileNumber of profiles
Central Pharmacy Logistics Australia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Central Pharmacy Logistics Australia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Central Pharmacy Logistics Australia
What does Central Pharmacy Logistics Australia do?
Central Pharmacy Logistics Australia provides Direct-to-Patient (DTP) delivery and Direct-From-Patient (DFP) collection of investigational products for clinical drug trials across Australia. Services are anchored at a TGA-licensed, GMP-compliant Melbourne depot operated by GMP/GCP-trained pharmacists, supported by premium couriers who deliver investigational products to and from patients' homes, enabling decentralised clinical trials.
Is Central Pharmacy Logistics Australia a public or private company?
Central Pharmacy Logistics Australia is a private company. It is currently operating.
When was Central Pharmacy Logistics Australia founded?
Central Pharmacy Logistics Australia was founded in 2019. It employs 11 to 50 people.
Where is Central Pharmacy Logistics Australia based?
Central Pharmacy Logistics Australia is headquartered in Melbourne, Australia, in the Oceania region.
How does Central Pharmacy Logistics Australia make money?
One revenue line is on record: clinical Trial Supply Chain Services.
Who are Central Pharmacy Logistics Australia's main competitors?
Direct peers on record are Marken, Biocair, World Courier, Movianto and Yourway Transport. Emerging players are Cryoport Systems and Clinipace Worldwide (or dMed Global). Broad incumbents are Almac Group, DHL Supply Chain (Life Sciences) and Fisher Clinical Services (Thermo Fisher Scientific).
Does Central Pharmacy Logistics Australia have an API?
No public API is recorded for Central Pharmacy Logistics Australia.
What industry is Central Pharmacy Logistics Australia in?
Its primary akta.pro industry code is HLAGAMAC, Clinical Trial Logistics & Depot Services (IRT-integrated, kitting, returns), with a secondary code of TLAIACAD, Pharmaceutical & Life Sciences Warehousing (GDP-Compliant). Its NAICS code is 424210 and its SIC code is 5122.